Topiramate — an antiseizure medication prescribed to treat epilepsy as well as migraines and bipolar disorder — does not appear to increase the risk of autism spectrum disorder (ASD) among children exposed to it prenatally, according to a new study led by Harvard T.H. Chan School of Public Health.

HMS News article on new research from Christopher A. Walsh and Kristopher T. Kahle, co-first authors Sattar Khoshkhoo and Yilan Wang, examining the role of somatic mutations — DNA alterations that occur after conception — in Temporal Lobe Epilepsy (TLE) and suggesting the potential of using existing cancer therapies to treat TLE that is resistant to anti-seizure medications.

New research from the labs of Bruce Yanker and colleagues, co-first authors Joseph Zullo and Derek Drake, shows that neural activity emerges as a factor in longevity.